Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.95315525 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.78674754 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.78674754 |
4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.63770672 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.54288797 |
6 | regulation of gamma-delta T cell activation (GO:0046643) | 5.36647002 |
7 | positive regulation of B cell differentiation (GO:0045579) | 5.04689377 |
8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.92738744 |
9 | B cell receptor signaling pathway (GO:0050853) | 4.69857834 |
10 | regulation of B cell differentiation (GO:0045577) | 4.49407640 |
11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.44454930 |
12 | positive thymic T cell selection (GO:0045059) | 4.24740345 |
13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.22207638 |
14 | negative regulation of cell killing (GO:0031342) | 4.22207638 |
15 | NIK/NF-kappaB signaling (GO:0038061) | 4.21333124 |
16 | negative T cell selection (GO:0043383) | 4.15345500 |
17 | detection of other organism (GO:0098543) | 4.11221443 |
18 | detection of bacterium (GO:0016045) | 4.03809024 |
19 | leukocyte aggregation (GO:0070486) | 3.99901514 |
20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.97067340 |
21 | negative regulation of T cell mediated immunity (GO:0002710) | 3.96349389 |
22 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.87201310 |
23 | negative thymic T cell selection (GO:0045060) | 3.85887631 |
24 | positive T cell selection (GO:0043368) | 3.84869265 |
25 | macrophage activation involved in immune response (GO:0002281) | 3.83699781 |
26 | response to peptidoglycan (GO:0032494) | 3.77184396 |
27 | negative regulation of phagocytosis (GO:0050765) | 3.74994628 |
28 | T cell selection (GO:0045058) | 3.70954217 |
29 | V(D)J recombination (GO:0033151) | 3.69437543 |
30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.69224266 |
31 | T cell homeostasis (GO:0043029) | 3.67965464 |
32 | T cell migration (GO:0072678) | 3.65133205 |
33 | negative regulation of interleukin-12 production (GO:0032695) | 3.61105339 |
34 | response to interleukin-15 (GO:0070672) | 3.59467403 |
35 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.56000100 |
36 | thymic T cell selection (GO:0045061) | 3.48229320 |
37 | cellular response to zinc ion (GO:0071294) | 3.46423603 |
38 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.45734451 |
39 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.44913357 |
40 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.40523189 |
41 | lymphocyte homeostasis (GO:0002260) | 3.38422570 |
42 | B cell mediated immunity (GO:0019724) | 3.36110381 |
43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.35442441 |
44 | myeloid cell activation involved in immune response (GO:0002275) | 3.32283451 |
45 | myeloid dendritic cell activation (GO:0001773) | 3.28476767 |
46 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.28355635 |
47 | cellular extravasation (GO:0045123) | 3.27796427 |
48 | neutrophil activation (GO:0042119) | 3.27677768 |
49 | positive regulation of interleukin-2 production (GO:0032743) | 3.26911571 |
50 | detection of external biotic stimulus (GO:0098581) | 3.26206197 |
51 | regulation of antigen processing and presentation (GO:0002577) | 3.24914752 |
52 | T cell receptor signaling pathway (GO:0050852) | 3.23131010 |
53 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.21240305 |
54 | respiratory burst (GO:0045730) | 3.16298279 |
55 | tolerance induction (GO:0002507) | 3.16130106 |
56 | cellular response to interleukin-15 (GO:0071350) | 3.16000180 |
57 | natural killer cell differentiation (GO:0001779) | 3.15867329 |
58 | response to host immune response (GO:0052572) | 3.14759862 |
59 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.14759862 |
60 | interferon-gamma production (GO:0032609) | 3.13465973 |
61 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.11129903 |
62 | response to muramyl dipeptide (GO:0032495) | 3.09992465 |
63 | microglial cell activation (GO:0001774) | 3.09367719 |
64 | regulation of mast cell degranulation (GO:0043304) | 3.09228978 |
65 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.08716171 |
66 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.08716171 |
67 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.06634951 |
68 | activated T cell proliferation (GO:0050798) | 3.06116419 |
69 | B cell proliferation (GO:0042100) | 3.05919916 |
70 | leukocyte homeostasis (GO:0001776) | 3.04641234 |
71 | immunoglobulin mediated immune response (GO:0016064) | 3.03463543 |
72 | Peyers patch development (GO:0048541) | 3.02585212 |
73 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.02585212 |
74 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.02341109 |
75 | neutrophil activation involved in immune response (GO:0002283) | 3.02129611 |
76 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.01747415 |
77 | mast cell activation (GO:0045576) | 3.01578484 |
78 | regulation of germinal center formation (GO:0002634) | 3.00729494 |
79 | leukocyte degranulation (GO:0043299) | 2.99354475 |
80 | T cell costimulation (GO:0031295) | 2.98677948 |
81 | mature B cell differentiation (GO:0002335) | 2.96946841 |
82 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.94765669 |
83 | myeloid dendritic cell differentiation (GO:0043011) | 2.94551406 |
84 | granulocyte activation (GO:0036230) | 2.93338359 |
85 | positive regulation of mast cell activation (GO:0033005) | 2.93095762 |
86 | negative regulation of granulocyte differentiation (GO:0030853) | 2.93056088 |
87 | lymphocyte costimulation (GO:0031294) | 2.92881887 |
88 | regulation of necroptotic process (GO:0060544) | 2.92845512 |
89 | positive regulation of interferon-alpha production (GO:0032727) | 2.90723507 |
90 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.90385451 |
91 | regulation of mast cell activation (GO:0033003) | 2.89748268 |
92 | B cell homeostasis (GO:0001782) | 2.88577697 |
93 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88193393 |
94 | germinal center formation (GO:0002467) | 2.87115781 |
95 | response to host (GO:0075136) | 2.87003556 |
96 | response to host defenses (GO:0052200) | 2.87003556 |
97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.87003556 |
98 | regulation of interferon-alpha production (GO:0032647) | 2.86763729 |
99 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.86402956 |
100 | detection of biotic stimulus (GO:0009595) | 2.85718270 |
101 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.85477478 |
102 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.85304169 |
103 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.84817918 |
104 | regulation of T cell tolerance induction (GO:0002664) | 2.79752010 |
105 | natural killer cell activation (GO:0030101) | 2.79602181 |
106 | defense response to protozoan (GO:0042832) | 2.78964082 |
107 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.78035796 |
108 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.77464025 |
109 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.77459910 |
110 | positive regulation of antigen processing and presentation (GO:0002579) | 2.76549553 |
111 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.75674761 |
112 | mononuclear cell proliferation (GO:0032943) | 2.74543678 |
113 | leukocyte cell-cell adhesion (GO:0007159) | 2.72453709 |
114 | lymphocyte proliferation (GO:0046651) | 2.72391186 |
115 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.71229350 |
116 | response to protozoan (GO:0001562) | 2.70270034 |
117 | positive regulation of B cell activation (GO:0050871) | 2.69892517 |
118 | modulation by symbiont of host defense response (GO:0052031) | 2.69832304 |
119 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.69832304 |
120 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.69832304 |
121 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.69832304 |
122 | modulation by symbiont of host immune response (GO:0052553) | 2.69832304 |
123 | positive regulation by symbiont of host defense response (GO:0052509) | 2.69832304 |
124 | positive regulation of granulocyte differentiation (GO:0030854) | 2.69413050 |
125 | hepatocyte apoptotic process (GO:0097284) | 2.69392649 |
126 | T cell proliferation (GO:0042098) | 2.68971975 |
127 | lymph node development (GO:0048535) | 2.68845536 |
128 | regulation of response to interferon-gamma (GO:0060330) | 2.66782979 |
129 | response to type I interferon (GO:0034340) | 2.66735249 |
130 | regulation of regulatory T cell differentiation (GO:0045589) | 2.65092111 |
131 | regulation of granulocyte differentiation (GO:0030852) | 2.64960346 |
132 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.62452594 |
133 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.60456875 |
134 | positive regulation of histone deacetylation (GO:0031065) | 2.59717538 |
135 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.59015812 |
136 | type I interferon signaling pathway (GO:0060337) | 2.58976245 |
137 | cellular response to type I interferon (GO:0071357) | 2.58976245 |
138 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.57879173 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.22474036 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.78150972 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.69159715 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.48364856 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.62309650 |
6 | MYC_22102868_ChIP-Seq_BL_Human | 3.51507216 |
7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.51201372 |
8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44186601 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.41458590 |
10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.06191838 |
11 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.05080168 |
12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.82543361 |
13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.79634992 |
14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.75285508 |
15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.74637050 |
16 | * MYB_26560356_Chip-Seq_TH2_Human | 2.71230200 |
17 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.66849881 |
18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65150470 |
19 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.63920529 |
20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.61619019 |
21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.60472532 |
22 | * MAF_26560356_Chip-Seq_TH1_Human | 2.58614503 |
23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.53459465 |
24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.41697918 |
25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39967365 |
26 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34951606 |
27 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.33432165 |
28 | * MYB_26560356_Chip-Seq_TH1_Human | 2.33135362 |
29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.28403400 |
30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26173779 |
31 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.23779718 |
32 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.18020229 |
33 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.17587296 |
34 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.05480643 |
35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.02248513 |
36 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99835537 |
37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96792553 |
38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.81584356 |
39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78226412 |
40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73039204 |
41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.71660523 |
42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.70907767 |
43 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67268300 |
44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66361376 |
45 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.65876768 |
46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64595994 |
47 | MAF_26560356_Chip-Seq_TH2_Human | 1.58785086 |
48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.57700632 |
49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52514152 |
50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50991535 |
51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49552299 |
52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47597746 |
53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.46970196 |
54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46796621 |
55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46600168 |
56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45475990 |
57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.42389601 |
58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37114501 |
59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.35454385 |
60 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.34263691 |
61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28674099 |
62 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.26968450 |
63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26369730 |
64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25047538 |
65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.22870660 |
66 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21769503 |
67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21441220 |
68 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.21193453 |
69 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20998724 |
70 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20391939 |
71 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.19442631 |
72 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.18494555 |
73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.17766298 |
74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16679819 |
75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13334233 |
76 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.12919357 |
77 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12258060 |
78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10992112 |
79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07548197 |
80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05837707 |
81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05828669 |
82 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.02331437 |
83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00830352 |
84 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00722315 |
85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96861881 |
86 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95063853 |
87 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94618762 |
88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94424609 |
89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93809335 |
90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91367215 |
91 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91298735 |
92 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.90768232 |
93 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90439782 |
94 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.89276149 |
95 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88291986 |
96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85639096 |
97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85076476 |
98 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84953896 |
99 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.84788587 |
100 | P300_27268052_Chip-Seq_Bcells_Human | 0.83519945 |
101 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.83200035 |
102 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83182586 |
103 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82828941 |
104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80549897 |
105 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.78799793 |
106 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76764724 |
107 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73036737 |
108 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72218941 |
109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71858595 |
110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71575260 |
111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70020004 |
112 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.69819275 |
113 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.69032191 |
114 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68351756 |
115 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.67708055 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.93494308 |
2 | MP0000685_abnormal_immune_system | 3.52764990 |
3 | MP0005671_abnormal_response_to | 3.27213944 |
4 | MP0001800_abnormal_humoral_immune | 3.18786039 |
5 | MP0005387_immune_system_phenotype | 3.03702657 |
6 | MP0001790_abnormal_immune_system | 3.03702657 |
7 | MP0003763_abnormal_thymus_physiology | 2.96801569 |
8 | MP0002166_altered_tumor_susceptibility | 2.83167303 |
9 | MP0002396_abnormal_hematopoietic_system | 2.81802671 |
10 | MP0009785_altered_susceptibility_to | 2.73775220 |
11 | MP0002452_abnormal_antigen_presenting | 2.72185385 |
12 | MP0002420_abnormal_adaptive_immunity | 2.58795468 |
13 | MP0005000_abnormal_immune_tolerance | 2.56686724 |
14 | MP0001819_abnormal_immune_cell | 2.56469297 |
15 | MP0002723_abnormal_immune_serum | 2.56120892 |
16 | MP0002398_abnormal_bone_marrow | 2.56093284 |
17 | MP0003303_peritoneal_inflammation | 2.47531858 |
18 | MP0003436_decreased_susceptibility_to | 2.46264686 |
19 | MP0009278_abnormal_bone_marrow | 2.40276206 |
20 | MP0005025_abnormal_response_to | 2.30495033 |
21 | MP0000716_abnormal_immune_system | 2.28410439 |
22 | MP0004808_abnormal_hematopoietic_stem | 2.22821908 |
23 | MP0002419_abnormal_innate_immunity | 2.20973846 |
24 | MP0002006_tumorigenesis | 2.16545186 |
25 | MP0002148_abnormal_hypersensitivity_rea | 2.14261039 |
26 | MP0000689_abnormal_spleen_morphology | 2.11512449 |
27 | MP0004510_myositis | 2.11051775 |
28 | MP0000703_abnormal_thymus_morphology | 2.07339118 |
29 | MP0002722_abnormal_immune_system | 2.06622727 |
30 | MP0002405_respiratory_system_inflammati | 1.97732439 |
31 | MP0002429_abnormal_blood_cell | 1.91728779 |
32 | MP0010155_abnormal_intestine_physiology | 1.91377889 |
33 | MP0001853_heart_inflammation | 1.90816595 |
34 | MP0005464_abnormal_platelet_physiology | 1.89205587 |
35 | MP0001545_abnormal_hematopoietic_system | 1.86885703 |
36 | MP0005397_hematopoietic_system_phenotyp | 1.86885703 |
37 | MP0003300_gastrointestinal_ulcer | 1.84517110 |
38 | MP0001873_stomach_inflammation | 1.84073316 |
39 | MP0005451_abnormal_body_composition | 1.74400237 |
40 | MP0009333_abnormal_splenocyte_physiolog | 1.71632359 |
41 | MP0004947_skin_inflammation | 1.70695985 |
42 | MP0001845_abnormal_inflammatory_respons | 1.55373032 |
43 | MP0003828_pulmonary_edema | 1.52087997 |
44 | MP0002138_abnormal_hepatobiliary_system | 1.48547152 |
45 | MP0003724_increased_susceptibility_to | 1.48498823 |
46 | MP0006082_CNS_inflammation | 1.44719910 |
47 | MP0002933_joint_inflammation | 1.38173283 |
48 | MP0001879_abnormal_lymphatic_vessel | 1.32017146 |
49 | MP0004381_abnormal_hair_follicle | 1.31876046 |
50 | MP0008057_abnormal_DNA_replication | 1.28470134 |
51 | MP0000465_gastrointestinal_hemorrhage | 1.28286374 |
52 | MP0005174_abnormal_tail_pigmentation | 1.25381955 |
53 | MP0010094_abnormal_chromosome_stability | 1.24473721 |
54 | MP0003866_abnormal_defecation | 1.22963677 |
55 | MP0000490_abnormal_crypts_of | 1.16244340 |
56 | MP0008469_abnormal_protein_level | 1.08979200 |
57 | MP0002009_preneoplasia | 1.07883947 |
58 | MP0001533_abnormal_skeleton_physiology | 1.06632692 |
59 | MP0008260_abnormal_autophagy | 1.04628365 |
60 | MP0002019_abnormal_tumor_incidence | 1.04184043 |
61 | MP0001986_abnormal_taste_sensitivity | 1.00629629 |
62 | MP0003646_muscle_fatigue | 1.00566791 |
63 | MP0005310_abnormal_salivary_gland | 0.99390913 |
64 | MP0003077_abnormal_cell_cycle | 0.96644143 |
65 | MP0000858_altered_metastatic_potential | 0.95394217 |
66 | MP0000015_abnormal_ear_pigmentation | 0.95382888 |
67 | MP0003448_altered_tumor_morphology | 0.95199554 |
68 | MP0010352_gastrointestinal_tract_polyps | 0.94686630 |
69 | MP0003191_abnormal_cellular_cholesterol | 0.92795805 |
70 | MP0004883_abnormal_blood_vessel | 0.91780971 |
71 | MP0002095_abnormal_skin_pigmentation | 0.89356202 |
72 | MP0010630_abnormal_cardiac_muscle | 0.89116344 |
73 | MP0004084_abnormal_cardiac_muscle | 0.88473818 |
74 | MP0000343_altered_response_to | 0.87578679 |
75 | MP0005076_abnormal_cell_differentiation | 0.85818934 |
76 | MP0003183_abnormal_peptide_metabolism | 0.83137901 |
77 | MP0003656_abnormal_erythrocyte_physiolo | 0.82975993 |
78 | MP0002332_abnormal_exercise_endurance | 0.82425375 |
79 | MP0008007_abnormal_cellular_replicative | 0.82404267 |
80 | MP0002132_abnormal_respiratory_system | 0.81770120 |
81 | MP0003806_abnormal_nucleotide_metabolis | 0.80937591 |
82 | MP0009764_decreased_sensitivity_to | 0.80702102 |
83 | MP0005166_decreased_susceptibility_to | 0.79798708 |
84 | MP0005075_abnormal_melanosome_morpholog | 0.78253607 |
85 | MP0001663_abnormal_digestive_system | 0.77859200 |
86 | MP0003693_abnormal_embryo_hatching | 0.76867731 |
87 | MP0000569_abnormal_digit_pigmentation | 0.76612917 |
88 | MP0003075_altered_response_to | 0.74886399 |
89 | MP0000249_abnormal_blood_vessel | 0.74876296 |
90 | MP0000767_abnormal_smooth_muscle | 0.74205042 |
91 | MP0003045_fibrosis | 0.71312700 |
92 | MP0003566_abnormal_cell_adhesion | 0.70174227 |
93 | MP0003279_aneurysm | 0.69805919 |
94 | MP0001851_eye_inflammation | 0.69273574 |
95 | MP0005058_abnormal_lysosome_morphology | 0.68219014 |
96 | MP0006054_spinal_hemorrhage | 0.68020948 |
97 | MP0010307_abnormal_tumor_latency | 0.65670649 |
98 | MP0003172_abnormal_lysosome_physiology | 0.65657837 |
99 | MP0002998_abnormal_bone_remodeling | 0.65524952 |
100 | MP0003111_abnormal_nucleus_morphology | 0.65347660 |
101 | MP0004036_abnormal_muscle_relaxation | 0.64669075 |
102 | MP0008058_abnormal_DNA_repair | 0.64444571 |
103 | MP0004130_abnormal_muscle_cell | 0.64360436 |
104 | MP0000313_abnormal_cell_death | 0.63692427 |
105 | MP0003690_abnormal_glial_cell | 0.63629754 |
106 | MP0009765_abnormal_xenobiotic_induced | 0.63056537 |
107 | MP0002928_abnormal_bile_duct | 0.60825163 |
108 | MP0008874_decreased_physiological_sensi | 0.58256083 |
109 | MP0004087_abnormal_muscle_fiber | 0.57412756 |
110 | MP0008004_abnormal_stomach_pH | 0.57384948 |
111 | MP0000604_amyloidosis | 0.56922881 |
112 | MP0005164_abnormal_response_to | 0.56821267 |
113 | MP0005266_abnormal_metabolism | 0.56534385 |
114 | MP0009763_increased_sensitivity_to | 0.56520777 |
115 | MP0002693_abnormal_pancreas_physiology | 0.55829515 |
116 | MP0003943_abnormal_hepatobiliary_system | 0.55021742 |
117 | MP0005390_skeleton_phenotype | 0.55002397 |
118 | MP0001544_abnormal_cardiovascular_syste | 0.54918920 |
119 | MP0005385_cardiovascular_system_phenoty | 0.54918920 |
120 | MP0005023_abnormal_wound_healing | 0.54662685 |
121 | MP0008961_abnormal_basal_metabolism | 0.54556716 |
122 | MP0004484_altered_response_of | 0.51487717 |
123 | MP0005376_homeostasis/metabolism_phenot | 0.49005991 |
124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.48950632 |
125 | MP0002277_abnormal_respiratory_mucosa | 0.48618622 |
126 | MP0003795_abnormal_bone_structure | 0.46971433 |
127 | MP0005535_abnormal_body_temperature | 0.46432867 |
128 | MP0009115_abnormal_fat_cell | 0.45581205 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent viral infections (HP:0004429) | 5.39438487 |
2 | Panhypogammaglobulinemia (HP:0003139) | 5.33502837 |
3 | Agammaglobulinemia (HP:0004432) | 5.03282013 |
4 | B lymphocytopenia (HP:0010976) | 4.94891998 |
5 | Abnormality of B cell number (HP:0010975) | 4.94891998 |
6 | T lymphocytopenia (HP:0005403) | 4.81738627 |
7 | Thyroiditis (HP:0100646) | 4.70457147 |
8 | Abnormality of T cell number (HP:0011839) | 4.67870578 |
9 | Recurrent fungal infections (HP:0002841) | 4.65849478 |
10 | Recurrent abscess formation (HP:0002722) | 4.51107976 |
11 | Cellulitis (HP:0100658) | 4.31779691 |
12 | Chronic otitis media (HP:0000389) | 4.27216434 |
13 | Recurrent bacterial skin infections (HP:0005406) | 4.11178005 |
14 | Meningitis (HP:0001287) | 4.11029731 |
15 | Eosinophilia (HP:0001880) | 4.00718342 |
16 | Severe combined immunodeficiency (HP:0004430) | 4.00004976 |
17 | Recurrent bronchitis (HP:0002837) | 3.99820516 |
18 | Eczematoid dermatitis (HP:0000976) | 3.95025301 |
19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.82715707 |
20 | IgM deficiency (HP:0002850) | 3.81126489 |
21 | Verrucae (HP:0200043) | 3.77507404 |
22 | Papilloma (HP:0012740) | 3.77507404 |
23 | Abnormality of T cells (HP:0002843) | 3.70167734 |
24 | Combined immunodeficiency (HP:0005387) | 3.60938599 |
25 | Granulocytopenia (HP:0001913) | 3.55113064 |
26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.53831160 |
27 | Abnormality of the fingertips (HP:0001211) | 3.49891234 |
28 | Myositis (HP:0100614) | 3.47721900 |
29 | Gastrointestinal infarctions (HP:0005244) | 3.44891567 |
30 | Hypoplasia of the thymus (HP:0000778) | 3.38558808 |
31 | Colitis (HP:0002583) | 3.35045848 |
32 | Inflammation of the large intestine (HP:0002037) | 3.33700037 |
33 | Gastrointestinal inflammation (HP:0004386) | 3.27324277 |
34 | Abnormality of eosinophils (HP:0001879) | 3.27099009 |
35 | Recurrent cutaneous fungal infections (HP:0011370) | 3.22077386 |
36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.22077386 |
37 | Mediastinal lymphadenopathy (HP:0100721) | 3.20164626 |
38 | Spontaneous hematomas (HP:0007420) | 3.17268593 |
39 | Autoimmune hemolytic anemia (HP:0001890) | 3.11808125 |
40 | IgG deficiency (HP:0004315) | 3.11771255 |
41 | Recurrent skin infections (HP:0001581) | 3.07039355 |
42 | Leukocytosis (HP:0001974) | 3.01539405 |
43 | Gastrointestinal stroma tumor (HP:0100723) | 2.95927762 |
44 | Lymphopenia (HP:0001888) | 2.91944080 |
45 | Thrombocytosis (HP:0001894) | 2.91882722 |
46 | Osteomyelitis (HP:0002754) | 2.89659781 |
47 | Vasculitis (HP:0002633) | 2.88499952 |
48 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.87312482 |
49 | Increased IgM level (HP:0003496) | 2.84255336 |
50 | Nasal polyposis (HP:0100582) | 2.79778261 |
51 | Abnormality of the nasal mucosa (HP:0000433) | 2.73427677 |
52 | Urticaria (HP:0001025) | 2.72896277 |
53 | Chronic sinusitis (HP:0011109) | 2.70154366 |
54 | Abnormality of T cell physiology (HP:0011840) | 2.69314377 |
55 | Autoimmune thrombocytopenia (HP:0001973) | 2.67673589 |
56 | Hematochezia (HP:0002573) | 2.59912918 |
57 | Obstructive lung disease (HP:0006536) | 2.59912474 |
58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.59912474 |
59 | Sepsis (HP:0100806) | 2.59195660 |
60 | Hypoproteinemia (HP:0003075) | 2.58692989 |
61 | Pustule (HP:0200039) | 2.44931960 |
62 | Encephalitis (HP:0002383) | 2.42459083 |
63 | Prolonged bleeding time (HP:0003010) | 2.41665346 |
64 | Optic neuritis (HP:0100653) | 2.39703452 |
65 | Retrobulbar optic neuritis (HP:0100654) | 2.39703452 |
66 | Abnormality of the pleura (HP:0002103) | 2.38028930 |
67 | Orchitis (HP:0100796) | 2.36463253 |
68 | Recurrent sinusitis (HP:0011108) | 2.35644435 |
69 | Chronic diarrhea (HP:0002028) | 2.34761285 |
70 | Lymphoma (HP:0002665) | 2.34603810 |
71 | Pulmonary embolism (HP:0002204) | 2.34252108 |
72 | Abnormality of macrophages (HP:0004311) | 2.33045790 |
73 | IgA deficiency (HP:0002720) | 2.30645791 |
74 | Increased IgE level (HP:0003212) | 2.29594347 |
75 | Chest pain (HP:0100749) | 2.29427882 |
76 | Arterial thrombosis (HP:0004420) | 2.28549748 |
77 | Recurrent pneumonia (HP:0006532) | 2.27995860 |
78 | Stomatitis (HP:0010280) | 2.26250168 |
79 | Pulmonary infiltrates (HP:0002113) | 2.25310181 |
80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24916752 |
81 | Episodic fever (HP:0001954) | 2.23733589 |
82 | Gangrene (HP:0100758) | 2.21475179 |
83 | Hypochromic anemia (HP:0001931) | 2.21014983 |
84 | Emphysema (HP:0002097) | 2.18842875 |
85 | Anorexia (HP:0002039) | 2.15562423 |
86 | Skin ulcer (HP:0200042) | 2.15348078 |
87 | Fatigue (HP:0012378) | 2.14424992 |
88 | Recurrent lower respiratory tract infections (HP:0002783) | 2.11275649 |
89 | Periodontitis (HP:0000704) | 2.09488029 |
90 | Hemoptysis (HP:0002105) | 2.08980433 |
91 | Bronchitis (HP:0012387) | 2.04878202 |
92 | Acute hepatic failure (HP:0006554) | 2.01449491 |
93 | Gingivitis (HP:0000230) | 1.99346206 |
94 | Epistaxis (HP:0000421) | 1.98187422 |
95 | Keratoconjunctivitis sicca (HP:0001097) | 1.96156112 |
96 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.95503939 |
97 | Polyneuropathy (HP:0001271) | 1.94429320 |
98 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.93786780 |
99 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.92910420 |
100 | Subaortic stenosis (HP:0001682) | 1.92910420 |
101 | Abnormality of the endocardium (HP:0004306) | 1.91850795 |
102 | Interstitial pulmonary disease (HP:0006530) | 1.91815908 |
103 | Amaurosis fugax (HP:0100576) | 1.90703482 |
104 | Vertigo (HP:0002321) | 1.90197938 |
105 | Hypochromic microcytic anemia (HP:0004840) | 1.88422852 |
106 | Acute myeloid leukemia (HP:0004808) | 1.85665218 |
107 | Bicuspid aortic valve (HP:0001647) | 1.85218649 |
108 | Abnormality of the prostate (HP:0008775) | 1.84506009 |
109 | Restrictive lung disease (HP:0002091) | 1.83630496 |
110 | Skin rash (HP:0000988) | 1.83072557 |
111 | Petechiae (HP:0000967) | 1.82216119 |
112 | Keratoconjunctivitis (HP:0001096) | 1.77661529 |
113 | Viral hepatitis (HP:0006562) | 1.75071149 |
114 | Leukopenia (HP:0001882) | 1.74337724 |
115 | Hypergammaglobulinemia (HP:0010702) | 1.71664911 |
116 | Gingival bleeding (HP:0000225) | 1.69076481 |
117 | Neutropenia (HP:0001875) | 1.68985716 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.70326900 |
2 | MAP3K10 | 3.27269351 |
3 | PRPF4B | 2.62969444 |
4 | TYK2 | 2.62031671 |
5 | TXK | 2.49735879 |
6 | MAP3K14 | 2.41573007 |
7 | EEF2K | 2.35416112 |
8 | JAK3 | 2.31501092 |
9 | BTK | 2.22470598 |
10 | GRK6 | 2.21536363 |
11 | ZAP70 | 2.13852655 |
12 | STK10 | 2.09538442 |
13 | SYK | 1.99305094 |
14 | IRAK4 | 1.96896631 |
15 | CSF1R | 1.90030880 |
16 | KIT | 1.89024560 |
17 | TEC | 1.86504928 |
18 | ITK | 1.84268053 |
19 | TBK1 | 1.83587917 |
20 | PKN2 | 1.80388904 |
21 | FLT3 | 1.80382968 |
22 | BLK | 1.74979521 |
23 | JAK1 | 1.67384431 |
24 | IKBKE | 1.63088465 |
25 | RIPK4 | 1.62402283 |
26 | TGFBR2 | 1.59856275 |
27 | TTN | 1.52922959 |
28 | IKBKB | 1.51741153 |
29 | CLK1 | 1.49751765 |
30 | SIK2 | 1.42621401 |
31 | STK4 | 1.40089862 |
32 | MAP2K3 | 1.39900363 |
33 | HCK | 1.38820347 |
34 | MAP3K13 | 1.38471467 |
35 | CSK | 1.36245160 |
36 | ERN1 | 1.35891100 |
37 | LCK | 1.34480313 |
38 | BMPR2 | 1.33949958 |
39 | LRRK2 | 1.30566220 |
40 | FGFR3 | 1.28661559 |
41 | TESK2 | 1.26126294 |
42 | FGFR4 | 1.26050062 |
43 | NLK | 1.21200188 |
44 | TRIB3 | 1.19880307 |
45 | PIM1 | 1.19834487 |
46 | EPHB1 | 1.17577409 |
47 | MAP3K11 | 1.17152856 |
48 | FES | 1.12081525 |
49 | CDK12 | 1.09919920 |
50 | NEK2 | 1.08071197 |
51 | KDR | 1.04075558 |
52 | LYN | 1.00596188 |
53 | RPS6KA4 | 0.97776040 |
54 | MARK3 | 0.96925359 |
55 | CHUK | 0.96646057 |
56 | MAP3K7 | 0.95437608 |
57 | TRPM7 | 0.95437549 |
58 | FGR | 0.95042902 |
59 | IRAK3 | 0.94241873 |
60 | CDK4 | 0.92913206 |
61 | MAP3K1 | 0.88793769 |
62 | MAPK12 | 0.86223012 |
63 | MATK | 0.84290008 |
64 | STK24 | 0.82011832 |
65 | PTK6 | 0.80995714 |
66 | RPS6KB2 | 0.79565970 |
67 | IRAK1 | 0.77745602 |
68 | TAOK1 | 0.75327361 |
69 | MAP3K3 | 0.73950925 |
70 | JAK2 | 0.73296721 |
71 | SIK3 | 0.70249198 |
72 | PRKCQ | 0.69489373 |
73 | TAOK2 | 0.67291164 |
74 | OBSCN | 0.66957563 |
75 | MST4 | 0.66731705 |
76 | MAPK11 | 0.66095623 |
77 | MAPK4 | 0.65854997 |
78 | TGFBR1 | 0.65776091 |
79 | MARK2 | 0.62429321 |
80 | DMPK | 0.60695024 |
81 | GRK7 | 0.59525086 |
82 | NEK9 | 0.57921816 |
83 | HIPK2 | 0.57298397 |
84 | MAPK7 | 0.56368258 |
85 | CDK19 | 0.56272682 |
86 | YES1 | 0.53546560 |
87 | MAPKAPK3 | 0.53339933 |
88 | IRAK2 | 0.52183948 |
89 | CDK9 | 0.52037569 |
90 | CDK6 | 0.51383750 |
91 | TIE1 | 0.50885583 |
92 | PRKAA2 | 0.49804870 |
93 | MAP2K6 | 0.48941115 |
94 | NME2 | 0.48178804 |
95 | RPS6KA6 | 0.48126270 |
96 | CDC42BPA | 0.48094071 |
97 | MAP2K2 | 0.48084087 |
98 | PRKD2 | 0.44985827 |
99 | TAOK3 | 0.43782034 |
100 | FYN | 0.43737458 |
101 | MAP3K8 | 0.43368142 |
102 | PASK | 0.43096295 |
103 | MYLK | 0.41851182 |
104 | MELK | 0.41713259 |
105 | DYRK1B | 0.41649350 |
106 | BRD4 | 0.41130012 |
107 | KSR2 | 0.40804709 |
108 | PDPK1 | 0.40400259 |
109 | ZAK | 0.39320729 |
110 | ATR | 0.38317725 |
111 | TNK2 | 0.38132136 |
112 | CAMKK2 | 0.37271132 |
113 | MAP3K5 | 0.37112544 |
114 | CAMKK1 | 0.36661331 |
115 | RPS6KL1 | 0.36512273 |
116 | RPS6KC1 | 0.36512273 |
117 | TLK1 | 0.36478301 |
118 | SMG1 | 0.36133289 |
119 | PDGFRB | 0.34985077 |
120 | ABL1 | 0.34575259 |
121 | STK11 | 0.34487960 |
122 | CDC7 | 0.33273350 |
123 | BCKDK | 0.32358741 |
124 | PRKCH | 0.32055742 |
125 | PDK1 | 0.30588359 |
126 | SGK3 | 0.28477913 |
127 | CCNB1 | 0.27635168 |
128 | PRKD1 | 0.26967823 |
129 | MAPK3 | 0.25368791 |
130 | DYRK3 | 0.24249754 |
131 | PIK3CG | 0.24156122 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.89847069 |
2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.07226687 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.82797854 |
4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.50515859 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.45660418 |
6 | Measles_Homo sapiens_hsa05162 | 2.27320634 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27103903 |
8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.22731437 |
9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.21880391 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.02256349 |
11 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.98213669 |
12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.97634491 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89203977 |
14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.78525904 |
15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67857821 |
16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66451754 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64986524 |
18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.60931845 |
19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.60036266 |
20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58225824 |
21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.57946134 |
22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57279024 |
23 | Allograft rejection_Homo sapiens_hsa05330 | 1.55145029 |
24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51678228 |
25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.51647670 |
26 | DNA replication_Homo sapiens_hsa03030 | 1.45841869 |
27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44464117 |
28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38223646 |
29 | Base excision repair_Homo sapiens_hsa03410 | 1.37397737 |
30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.37150264 |
31 | Influenza A_Homo sapiens_hsa05164 | 1.35103849 |
32 | Apoptosis_Homo sapiens_hsa04210 | 1.30555291 |
33 | Hepatitis B_Homo sapiens_hsa05161 | 1.28957945 |
34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25773493 |
35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24486922 |
36 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.22603896 |
37 | Shigellosis_Homo sapiens_hsa05131 | 1.21225245 |
38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21142875 |
39 | Legionellosis_Homo sapiens_hsa05134 | 1.18833095 |
40 | Platelet activation_Homo sapiens_hsa04611 | 1.17305623 |
41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17240605 |
42 | Tuberculosis_Homo sapiens_hsa05152 | 1.16211418 |
43 | Pertussis_Homo sapiens_hsa05133 | 1.10265313 |
44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09646886 |
45 | HTLV-I infection_Homo sapiens_hsa05166 | 1.04484680 |
46 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03095484 |
47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00885369 |
48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98128842 |
49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97302233 |
50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.95916731 |
51 | Mismatch repair_Homo sapiens_hsa03430 | 0.94851859 |
52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94494153 |
53 | Malaria_Homo sapiens_hsa05144 | 0.91263578 |
54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88957678 |
55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88290380 |
56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83346017 |
57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80275407 |
58 | Phagosome_Homo sapiens_hsa04145 | 0.78735926 |
59 | Insulin resistance_Homo sapiens_hsa04931 | 0.78463289 |
60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77571034 |
61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76037531 |
62 | Asthma_Homo sapiens_hsa05310 | 0.74466014 |
63 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73508025 |
64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73466162 |
65 | Homologous recombination_Homo sapiens_hsa03440 | 0.70458755 |
66 | Salmonella infection_Homo sapiens_hsa05132 | 0.70406457 |
67 | Hepatitis C_Homo sapiens_hsa05160 | 0.69580595 |
68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68263688 |
69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65737992 |
70 | Cell cycle_Homo sapiens_hsa04110 | 0.65319135 |
71 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64923329 |
72 | Ribosome_Homo sapiens_hsa03010 | 0.63767267 |
73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63435750 |
74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62619114 |
75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61995290 |
76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61513479 |
77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61161390 |
78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61105793 |
79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59036374 |
80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58563359 |
81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58443112 |
82 | Spliceosome_Homo sapiens_hsa03040 | 0.58296973 |
83 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54496702 |
84 | Lysine degradation_Homo sapiens_hsa00310 | 0.54230911 |
85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51195392 |
86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47381350 |
87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47197150 |
88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45974963 |
89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45883283 |
90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45152123 |
91 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.44748565 |
92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.44706638 |
93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44203494 |
94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42285960 |
95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41864029 |
96 | Prostate cancer_Homo sapiens_hsa05215 | 0.41832723 |
97 | Lysosome_Homo sapiens_hsa04142 | 0.41662208 |
98 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41448581 |
99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41036835 |
100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40396649 |
101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39565889 |
102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37443949 |
103 | Focal adhesion_Homo sapiens_hsa04510 | 0.36314708 |
104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35933616 |
105 | RNA degradation_Homo sapiens_hsa03018 | 0.35456404 |
106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34558189 |
107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34054883 |
108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30815510 |
109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30349977 |
110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30094908 |
111 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.29623436 |
112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29352047 |
113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.29044013 |
114 | Endocytosis_Homo sapiens_hsa04144 | 0.28394518 |
115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27225885 |
116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27005531 |
117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26276490 |
118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26224245 |
119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26146612 |
120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.25420124 |
121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22249825 |
122 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.20335073 |
123 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.13486961 |
124 | Amoebiasis_Homo sapiens_hsa05146 | 0.12951331 |
125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.10480196 |